|
1
|
Zhang Y, Ren JS, Shi JF, Li N, Wang YT, Qu
C, Zhang Y and Dai M: International trends in primary liver cancer
incidence from 1973 to 2007. BMC Cancer. 15:942015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park GH, Song HM and Jeong JB: The coffee
diterpene kahweol suppresses the cell proliferation by inducing
cyclin D1 proteasomal degradation via ERK1/2, JNK and
GKS3β-dependent threonine-286 phosphorylation in human colorectal
cancer cells. Food Chem Toxicol. 95:142–148. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yuan C, Zhu X, Han Y, Song C, Liu C, Lu S,
Zhang M, Yu F, Peng Z and Zhou C: Elevated HOXA1 expression
correlates with accelerated tumor cell proliferation and poor
prognosis in gastric cancer partly via cyclin D1. J Exp Clin Cancer
Res. 35:152016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Quelle DE, Ashmun RA, Shurtleff SA, Kato
JY, Bar-Sagi D, Roussel MF and Sherr CJ: Overexpression of mouse
D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes
Dev. 7:1559–1571. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cohen EE, Zhu H, Lingen MW, Martin LE, Kuo
WL, Choi EA, Kocherginsky M, Parker JS, Chung CH and Rosner MR: A
feed-forward loop involving protein kinase Calpha and microRNAs
regulates tumor cell cycle. Cancer Res. 69:65–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin DH, Kim Y, Lee BB, Han J, Kim HK, Shim
YM and Kim DH: Metformin induces cell cycle arrest at the G1 phase
through E2F8 suppression in lung cancer cells. Oncotarget.
8:101509–101519. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Amorim R, Pinheiro C, Miranda-Gonçalves V,
Pereira H, Moyer MP, Preto A and Baltazar F: Monocarboxylate
transport inhibition potentiates the cytotoxic effect of
5-fluorouracil in colorectal cancer cells. Cancer Lett. 365:68–78.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li M, Wang Q, Lin W and Wang B: Regulation
of ovarian cancer cell adhesion and invasion by chloride channels.
Int J Gynecol Cancer. 19:526–530. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kang MK and Kang SK: Pharmacologic
blockade of chloride channel synergistically enhances apoptosis of
chemotherapeutic drug-resistant cancer stem cells. Biochem Biophys
Res Commun. 373:539–544. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kunzelmann K: Ion channels and cancer. J
Membr Biol. 205:159–173. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Arcangeli A, Crociani O, Lastraioli E,
Masi A, Pillozzi S and Becchetti A: Targeting ion channels in
cancer: A novel frontier in antineoplastic therapy. Curr Med Chem.
16:66–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Conti M: Targeting ion channels for new
strategies in cancer diagnosis and therapy. Curr Clin Pharmacol.
2:135–144. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guan YY, Wang GL and Zhou JG: The ClC-3
Cl− channel in cell volume regulation, proliferation and
apoptosis in vascular smooth muscle cells. Trends Pharmacol Sci.
27:290–296. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lemonnier L, Shuba Y, Crepin A, Roudbaraki
M, Slomianny C, Mauroy B, Nilius B, Prevarskaya N and Skryma R:
Bcl-2-dependent modulation of swelling-activated Cl−
current and CLC-3 expression in human prostate cancer epithelial
cells. Cancer Res. 64:4841–4848. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Weylandt KH, Nebrig M, Jansen-Rosseck N,
Amey JS, Carmena D, Wiedenmann B, Higgins CF and Sardini A: ClC-3
expression enhances etoposide resistance by increasing
acidification of the late endocytic compartment. Mol Cancer Ther.
6:979–986. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su J, Xu Y, Zhou L, Yu HM, Kang JS, Liu N,
Quan CS and Sun LK: Suppression of chloride channel 3 expression
facilitates sensitivity of human glioma U251 cells to cisplatin
through concomitant inhibition of Akt and autophagy. Anat Rec.
296:595–603. 2013. View
Article : Google Scholar
|
|
17
|
Xu Y, Zheng H, Kang JS, Zhang L, Su J, Li
HY and Sun LK: 5-Nitro-2-(3-phenylpropylamino) benzoic acid induced
drug resistance to cisplatin in human erythroleukemia cell lines.
Anat Rec. 294:945–952. 2011. View
Article : Google Scholar
|
|
18
|
Du S and Yang L: ClC-3 chloride channel
modulates the proliferation and migration of osteosarcoma cells via
AKT/GSK3β signaling pathway. Int J Clin Exp Pathol. 8:1622–1630.
2015.PubMed/NCBI
|
|
19
|
Bruix J and Sherman M: Practice Guidelines
Committee, American Association for the Study of Liver Diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
European Association For The Study Of The
LiverEuropean Organisation For Research And Treatment Of Cancer:
EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chan SL, Mo FK, Johnson PJ, Hui EP, Ma BB,
Ho WM, Lam KC, Chan AT, Mok TS and Yeo W: New utility of an old
marker: Serial alpha-fetoprotein measurement in predicting
radiologic response and survival of patients with hepatocellular
carcinoma undergoing systemic chemotherapy. J Clin Oncol.
27:446–452. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Keam B, Oh DY, Lee SH, Kim DW, Im SA, Kim
TY, Heo DS and Bang YJ: A phase II study of 5-fluorouracil and
cisplatin systemic chemotherapy for inoperable hepatocellular
carcinoma with α fetoprotein as a predictive and prognostic marker.
Mol Med Rep. 1:415–422. 2008.PubMed/NCBI
|
|
24
|
Ye D, Luo H, Lai Z, Zou L, Zhu L, Mao J,
Jacob T, Ye W, Wang L and Chen L: ClC-3 Chloride Channel Proteins
Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through
Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells.
Sci Rep. 6:302762016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wondergem R, Gong W, Monen SH, Dooley SN,
Gonce JL, Conner TD, Houser M, Ecay TW and Ferslew KE: Blocking
swelling-activated chloride current inhibits mouse liver cell
proliferation. J Physiol. 532:661–672. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ji X, Shen Y, Sun H and Gao X: A novel
anti-alpha-fetoprotein single-chain variable fragment displays
anti-tumor effects in HepG2 cells as a single agent or in
combination with paclitaxel. Tumour Biol. 37:10085–10096. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang L, He T, Cui H, Wang Y, Huang C and
Han F: Effects of AFP gene silencing on apoptosis and proliferation
of a hepatocellular carcinoma cell line. Discov Med. 14:115–124.
2012.PubMed/NCBI
|
|
28
|
Yu WF, Zhao YL, Wang K and Dong MM:
Inhibition of cell proliferation and arrest of cell cycle
progression by blocking chloride channels in human laryngeal cancer
cell line Hep-2. Neoplasma. 56:224–229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang B, Xie J, He HY, Huang EW, Cao QH,
Luo L, Liao YS and Guo Y: Suppression of CLC-3 chloride channel
reduces the aggressiveness of glioma through inhibiting nuclear
factor-κB pathway. Oncotarget. 8:63788–63798. 2017.PubMed/NCBI
|
